Literature DB >> 24956437

Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses.

Stéphane Haïk1, Jean-Philippe Brandel2.   

Abstract

In contrast with other neurodegenerative disorders associated to protein misfolding, human prion diseases include infectious forms (also called transmitted forms) such as kuru, iatrogenic Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease. The transmissible agent is thought to be solely composed of the abnormal isoform (PrP(Sc)) of the host-encoded prion protein that accumulated in the central nervous system of affected individuals. Compared to its normal counterpart, PrP(Sc) is β-sheet enriched and aggregated and its propagation is based on an autocatalytic conversion process. Increasing evidence supports the view that conformational variations of PrP(Sc) encoded the biological properties of the various prion strains that have been isolated by transmission studies in experimental models. Infectious forms of human prion diseases played a pivotal role in the emergence of the prion concept and in the characterization of the very unconventional properties of prions. They provide a unique model to understand how prion strains are selected and propagate in humans. Here, we review and discuss how genetic factors interplay with strain properties and route of transmission to influence disease susceptibility, incubation period and phenotypic expression in the light of the kuru epidemics due to ritual endocannibalism, the various series iatrogenic diseases secondary to extractive growth hormone treatment or dura mater graft and the epidemics of variant Creutzfeldt-Jakob disease linked to dietary exposure to the agent of bovine spongiform encephalopathy.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; Infectious forms; Kuru; Prion diseases; Prion strains

Mesh:

Substances:

Year:  2014        PMID: 24956437     DOI: 10.1016/j.meegid.2014.06.010

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  14 in total

1.  The Dark Matter of Nutrition: Dietary Signals Beyond Traditional Nutrients.

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2019-04

Review 2.  Developing Therapeutics for PrP Prion Diseases.

Authors:  Kurt Giles; Steven H Olson; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

3.  Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster.

Authors:  Kirby M Donnelly; Margaret M P Pearce
Journal:  J Vis Exp       Date:  2018-03-12       Impact factor: 1.355

4.  Is multiple system atrophy an infectious disease?

Authors:  Gregor Wenning; John Q Trojanowski; Horacio Kaufmann; Thomas Wisniewski; Walter A Rocca; Phillip A Low
Journal:  Ann Neurol       Date:  2018-01-14       Impact factor: 10.422

5.  Prion-based memory of heat stress in yeast.

Authors:  Tatiana A Chernova; Yury O Chernoff; Keith D Wilkinson
Journal:  Prion       Date:  2017-05-19       Impact factor: 3.931

6.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

7.  Experimental sheep BSE prions generate the vCJD phenotype when serially passaged in transgenic mice expressing human prion protein.

Authors:  Susan Joiner; Emmanuel A Asante; Jacqueline M Linehan; Lara Brock; Sebastian Brandner; Susan J Bellworthy; Marion M Simmons; James Hope; John Collinge; Jonathan D F Wadsworth
Journal:  J Neurol Sci       Date:  2017-12-29       Impact factor: 3.181

Review 8.  Amyloid assembly and disassembly.

Authors:  Edward Chuang; Acacia M Hori; Christina D Hesketh; James Shorter
Journal:  J Cell Sci       Date:  2018-04-13       Impact factor: 5.285

Review 9.  Prions, prion-like prionoids, and neurodegenerative disorders.

Authors:  Ashok Verma
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

10.  Plasma cholesterol level determines in vivo prion propagation.

Authors:  Véronique Perrier; Thibaud Imberdis; Pierre-André Lafon; Marina Cefis; Yunyun Wang; Elisabeth Huetter; Jacques-Damien Arnaud; Teresa Alvarez-Martinez; Naig Le Guern; Guillaume Maquart; Laurent Lagrost; Catherine Desrumaux
Journal:  J Lipid Res       Date:  2017-08-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.